The Use of Exhaled Nitric Oxide in Conjunction With the Asthma Control Test to Determine Asthma Control in Pediatric Patients

Akron Children's Hospital100 enrolled

Overview

The purpose of this study is to determine if exhaled nitric oxide (eNO) levels will be increased in pediatric patients with uncontrolled asthma as determined by the Asthma Control Test (ACT). During the study the investigators will also examine if the combination of eNO and ACT will better predict asthma control that either tool alone when compared to a medical provider's assessment of the patient's asthma control.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Asthma

Eligibility

Sex: ALLMin age: 6 YearsMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Clinical diagnosis of asthma by pediatric pulmonologist * Age 6-18 years Exclusion Criteria: * Age \<6 years or \>18 years * history of bronchopulmonary dysplasia * history of cystic fibrosis * history of primary ciliary dyskinesia * current acute asthma exacerbation * current acute viral upper respiratory infection * recent ingestion of nitrate-rich foods

Locations (1)

Akron Children's Hospital

Akron, Ohio, United States

Outcomes

Primary Outcomes

Exhaled nitric oxide level

Time frame: One office visit

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.